SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-559626
Filing Date
2016-04-27
Accepted
2016-04-27 16:32:04
Documents
8
Period of Report
2016-06-09
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d104091ddef14a.htm DEF 14A 533211
2 GRAPHIC g104091g03c53.jpg GRAPHIC 29171
3 GRAPHIC g104091pcpg001a.jpg GRAPHIC 13953
4 GRAPHIC g104091pcpg001b.jpg GRAPHIC 19030
5 GRAPHIC g104091pcpg001c.jpg GRAPHIC 3497
6 GRAPHIC g104091pcpg001d.jpg GRAPHIC 6919
7 GRAPHIC g104091pcpg001f.jpg GRAPHIC 15229
8 GRAPHIC g104091pcpg002a.jpg GRAPHIC 4804
  Complete submission text file 0001193125-16-559626.txt   662948
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 161595785
SIC: 2835 In Vitro & In Vivo Diagnostic Substances